Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility

被引:221
作者
Wang, XS
Ria, M
Kelmenson, PM
Eriksson, P
Higgins, DC
Samnegård, C
Petros, C
Rollins, J
Bennet, AM
Wiman, B
de Faire, U
Wennberg, C
Olsson, PG
Ishii, N
Sugamura, K
Hamsten, A
Forsman-Semb, K
Lagercrantz, J
Paigen, B
机构
[1] Jackson Lab, Bar Harbor, ME 04609 USA
[2] Karolinska Hosp, King Gustaf V Res Inst, Atherosclerosis Res Unit, Dept Med,Karolinska Inst, S-10401 Stockholm, Sweden
[3] Karolinska Hosp, Div Cardiovasc Epidemiol, Inst Environm Med, Karolinska Inst, S-10401 Stockholm, Sweden
[4] Karolinska Hosp, Div Clin Chem & Blood Coagulat, Dept Surg Sci, Karolinska Inst, S-10401 Stockholm, Sweden
[5] Karolinska Hosp, Karolinska Inst, Dept Cardiol, S-10401 Stockholm, Sweden
[6] AstraZeneca R&D, Molndal, Sweden
[7] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan
基金
美国国家卫生研究院;
关键词
D O I
10.1038/ng1524
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Ath1 is a quantitative trait locus on mouse chromosome 1 that renders C57BL/6 mice susceptible and C3H/He mice resistant to diet-induced atherosclerosis. The quantitative trait locus region encompasses 11 known genes, including Tnfsf4 ( also called Ox40l or Cd134l), which encodes OX40 ligand. Here we report that mice with targeted mutations of Tnfsf4 had significantly ( P <= 0.05) smaller atherosclerotic lesions than did control mice. In addition, mice overexpressing Tnfsf4 had significantly ( P <= 0.05) larger atherosclerotic lesions than did control mice. In two independent human populations, the less common allele of SNP rs3850641 in TNFSF4 was significantly more frequent ( P <= 0.05) in individuals with myocardial infarction than in controls. We therefore conclude that Tnfsf4 underlies Ath1 in mice and that polymorphisms in its human homolog TNFSF4 increase the risk of myocardial infarction in humans.
引用
收藏
页码:365 / 372
页数:8
相关论文
共 44 条
[1]   The nature and identification of quantitative trait loci: a community's view [J].
Abiola, O ;
Angel, JM ;
Avner, P ;
Bachmanov, AA ;
Belknap, JK ;
Bennett, B ;
Blankenhorn, EP ;
Blizard, DA ;
Bolivar, V ;
Brockmann, GA ;
Buck, KJ ;
Bureau, JF ;
Casley, WL ;
Chesler, EJ ;
Cheverud, JM ;
Churchill, GA ;
Cook, M ;
Crabbe, JC ;
Crusio, WE ;
Darvasi, A ;
de Haan, G ;
Demant, P ;
Doerge, RW ;
Elliott, RW ;
Farber, CR ;
Flaherty, L ;
Flint, J ;
Gershenfeld, H ;
Gu, JPGJ ;
Gu, WK ;
Himmelbauer, H ;
Hitzemann, R ;
Hsu, HC ;
Hunter, K ;
Iraqi, FA ;
Jansen, RC ;
Johnson, TE ;
Jones, BC ;
Kempermann, G ;
Lammert, F ;
Lu, L ;
Manly, KF ;
Matthews, DB ;
Medrano, JF ;
Mehrabian, M ;
Mittleman, G ;
Mock, BA ;
Mogil, JS ;
Montagutelli, X ;
Morahan, G .
NATURE REVIEWS GENETICS, 2003, 4 (11) :911-916
[2]   Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease [J].
Aprahamian, T ;
Rifkin, I ;
Bonegio, A ;
Hugel, B ;
Freyssinet, JM ;
Sato, K ;
Castellot, JJ ;
Walsh, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (08) :1121-1131
[3]  
Austen W G, 1975, Circulation, V51, P5
[4]   Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men [J].
Boquist, S ;
Ruotolo, G ;
Tang, R ;
Björkegren, J ;
Bond, MG ;
de Faire, U ;
Karpe, F ;
Hamsten, A .
CIRCULATION, 1999, 100 (07) :723-728
[5]   Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice [J].
Caligiuri, G ;
Nicoletti, A ;
Poirier, B ;
Hansson, GK .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (06) :745-753
[6]   T and B lymphocytes play a minor sole in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse [J].
Dansky, HM ;
Charlton, SA ;
Harper, MM ;
Smith, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4642-4646
[7]   Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction [J].
Edfeldt, K ;
Bennet, AM ;
Eriksson, P ;
Frostegård, J ;
Wiman, B ;
Hamsten, A ;
Hansson, GK ;
de Faire, U ;
Yan, ZQ .
EUROPEAN HEART JOURNAL, 2004, 25 (16) :1447-1453
[8]  
Emeson EE, 1996, AM J PATHOL, V149, P675
[9]   Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease [J].
Eriksson, P ;
Deguchi, H ;
Samnegård, A ;
Lundman, P ;
Boquist, S ;
Tornvall, P ;
Ericsson, CG ;
Bergstrand, L ;
Hansson, LO ;
Ye, S ;
Hamsten, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) :551-557
[10]   Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis. [J].
Geng Y.J. .
Current Atherosclerosis Reports, 2001, 3 (3) :234-242